Pharmacist Eddie Morales is leading the charge to unionize in Connecticut, Rhode Island, and New Jersey. For more information, go to www.cvsworker.com. Contact Eddie at [email protected] for ...
A high-dose flu vaccine lowered flu- and pneumonia-related hospital stays in patients with chronic lung disease, reinforcing flu and pneumococcal vaccinations. In a review of records assessing ...
Vaccination and natural infection both train the immune system, but only one route carries the added risk of long COVID and ...
COVID-19 vaccine resistance has shifted from acute ideological opposition toward broader apathy, a trend now spilling into ...
Editorial Board | Drug Topics Perry Cohen, PharmD, FAMC CEO, The Pharmacy Group LLC Irvine, CA David J. Fong, PharmD Vice President, Pharmacy Nurx Inc. A Telehealth Company Danville, CA Jennifer ...
Data show that commercially and Medicaid-insured children with chronic or immunocompromising conditions incur 2- to 3-fold higher costs. A retrospective cohort study using the Merative MarketScan ...
Eligibility required diary-confirmed perimenstrual attacks in ≥2 of 3 cycles and excluded chronic migraine and certain aura syndromes, strengthening interpretability for episodic menstrual patterns.
Large-scale linkage analyses suggest prenatal SARS‑CoV‑2 exposure is not associated with most neurodevelopmental or neurological diagnoses in early childhood. Restricting to pre–March 2022 births ...
FirstLight randomized 1 mg BID, 2 mg BID, or placebo; RadiantLight compared 2 mg BID with placebo in adults/adolescents with ESS ≥11 and ≥4 weekly cataplexy episodes. MWT latency increased 14.3–19.8 ...
James Barnes, CPhT, explains why respecting a patient's time isn't about speed and how he landed in the pharmacy by chance.
Aggregate OOP burden for generics exceeds brands due to utilization intensity, especially among Medicare beneficiaries with higher generic fill counts and near-parity annual OOP spending versus brands ...
Nirmatrelvir-ritonavir (Paxlovid) provided no measurable benefit for patients with long COVID, according to results from RECOVER-VITAL ( NCT05595369 ), a phase 2 randomized, double-blind, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results